These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11711724)

  • 21. Barrett's esophagus and gland cancer - the experience of one center.
    Nowicki A; Kula Z; Świerszczyńska A
    Pol Przegl Chir; 2018 May; 90(3):19-24. PubMed ID: 30015321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges.
    Pech O
    Adv Exp Med Biol; 2016; 908():99-109. PubMed ID: 27573769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
    DE Carli DM; Araujo AF; Fagundes RB
    Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications and Limitations in the Management Algorithm of Patients With Esophageal Adenocarcinoma: Positron Emission Tomography Computed Tomography.
    Fisichella PM
    JAMA Surg; 2015 Jun; 150(6):562. PubMed ID: 25902411
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvement in staging of esophageal cancer with the addition of positron emission tomography.
    Block MI; Patterson GA; Sundaresan RS; Bailey MS; Flanagan FL; Dehdashti F; Siegel BA; Cooper JD
    Ann Thorac Surg; 1997 Sep; 64(3):770-6; discussion 776-7. PubMed ID: 9307472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barrett esophagus and adenocarcinoma.
    Chen MY; Frederick MG
    Radiol Clin North Am; 1994 Nov; 32(6):1167-81. PubMed ID: 7972706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Positron emission tomography for preoperative lymph node diagnosis in esophageal carcinoma].
    Kneist W; Schreckenberger M; Bartenstein P; Grünwald F; Oberholzer K; Junginger T
    Chirurg; 2003 Oct; 74(10):922-30; discussion 929-30. PubMed ID: 14605734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia.
    Ott K; Weber WA; Fink U; Helmberger H; Becker K; Stein HJ; Müller J; Schwaiger M; Siewert JR
    World J Surg; 2003 Sep; 27(9):1035-9. PubMed ID: 12917760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esophageal Adenocarcinoma With Subscalp Metastasis as the First Manifestation Detected by 18F-FDG PET/CT.
    Xu T; Zhang X; Fu W; Zeng C; Chen Y
    Clin Nucl Med; 2020 Feb; 45(2):143-145. PubMed ID: 31833929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of endoscopic ultrasound in the diagnosis and management of Barrett's esophagus.
    Owens MM; Kimmey MB
    Gastrointest Endosc Clin N Am; 2003 Apr; 13(2):325-34. PubMed ID: 12916663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second primary Barrett's adenocarcinoma after 19 years.
    Riben M; Ilves R; McKenna BJ
    Ann Thorac Surg; 1999 Jun; 67(6):1796-8. PubMed ID: 10391301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is FDG-PET indicated for superficial esophageal cancer?
    Little SG; Rice TW; Bybel B; Mason DP; Murthy SC; Falk GW; Rybicki LA; Blackstone EH
    Eur J Cardiothorac Surg; 2007 May; 31(5):791-6. PubMed ID: 17337344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volumetric laser endomicroscopy in Barrett's esophagus: a feasibility study on histological correlation.
    Swager A; Boerwinkel DF; de Bruin DM; Weusten BL; Faber DJ; Meijer SL; van Leeuwen TG; Curvers WL; Bergman JJ
    Dis Esophagus; 2016 Aug; 29(6):505-12. PubMed ID: 25951873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenocarcinoma arising in Barrett esophagus: pathologic and radiologic features.
    Keen SJ; Dodd GD; Smith JL
    Mt Sinai J Med; 1984; 51(4):442-50. PubMed ID: 6333604
    [No Abstract]   [Full Text] [Related]  

  • 35. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.
    Meltzer CC; Luketich JD; Friedman D; Charron M; Strollo D; Meehan M; Urso GK; Dachille MA; Townsend DW
    Clin Nucl Med; 2000 Nov; 25(11):882-7. PubMed ID: 11079584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future of diagnosing neoplasia in Barrett's esophagus: volumetric laser endomicroscopy.
    Aziz M; Fatima R
    Clin J Gastroenterol; 2018 Jun; 11(3):179-183. PubMed ID: 29680981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic peritoneal seeding patterns demonstrated by FDG positron emission tomographic imaging.
    Lin EC; Lear J; Quaife RA
    Clin Nucl Med; 2001 Mar; 26(3):249-50. PubMed ID: 11245126
    [No Abstract]   [Full Text] [Related]  

  • 39. Volumetric Mapping of Barrett's Esophagus and Dysplasia With en face Optical Coherence Tomography Tethered Capsule.
    Liang K; Ahsen OO; Lee HC; Wang Z; Potsaid BM; Figueiredo M; Jayaraman V; Cable AE; Huang Q; Mashimo H; Fujimoto JG
    Am J Gastroenterol; 2016 Nov; 111(11):1664-1666. PubMed ID: 27808130
    [No Abstract]   [Full Text] [Related]  

  • 40. Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate.
    Ooi J; Wilson P; Walker G; Blaker P; DeMartino S; O'Donohue J; Reffitt D; Lanaspre E; Chang F; Meenan J; Dunn JM
    Endoscopy; 2017 Jun; 49(6):524-528. PubMed ID: 28399610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.